Drug Development Webinars
-
How Does Nanomilling Benefit Poorly Soluble APIs?
1/9/2024
Andrew Buis sheds light on the intricate yet transformative process of nanomilling, a technique that involves the pulverization and stabilization of particles.
-
The Art Of Formulation
1/9/2024
Ensure that your API is meticulously tested and validated at every stage, facilitating a seamless transition from discovery and development to the final market-ready product.
-
High Potency Manufacturing Solutions
1/9/2024
Observe our experts in action as they scale up projects using a range of techniques and dosage forms, progressing from formulation to the production of commercial-scale batches.
-
Manufacturing And Analytical Testing Solutions
1/9/2024
Explore this contract manufacturing services offering designed to streamline drug development programs, resulting in time and cost savings while expediting the journey to market.
-
Optimization-By-Design - A Critical Factor In Viral Vector Scale Up
12/14/2023
Learn how leveraging the expertise and capabilities of an experienced partner is a key factor in optimizing AAV processes using Design of Experiment (DoE), thereby reducing variability and risk.
-
Nitrosamine Impurities Deadline: Are Your Products Compliant?
12/5/2023
Learn how to select an experienced nitrosamine mitigation provider and how a tailored, quantified strategy can help you bring your product into compliance while maintaining control of the process.
-
The Fundamental Outsourcing Question All Sponsors Face
10/24/2023
To end our Outsourced Pharma Live event on strategies for quality and regulatory outsourcing challenges, Chief Editor Louis Garguilo emphasizes the crucial question to ask when selecting a CDMO.
-
How To Connect Quality And Regulatory “At The Hip”
10/24/2023
Our Outsourced Pharma Live panel of experts introduce challenges and strategies to ensure your internal – and external partners’ – quality and regulatory professionals work together.
-
File First In Europe, Then The U.S.?
10/24/2023
Karla Knower, Global Head of Regulatory Affairs, Paradigm Biopharmaceuticals, answers a challenging question from an attendee at a recent Outsourced Pharma Live.
-
The Nature Of Quality Management Needs To Change
10/24/2023
In these 3 minutes, Bikash Chatterjee, an Outsourced Pharma Board Member, discusses how the current drug development and manufacturing landscape necessitates different approaches for quality teams.